Physician

Bennjamin Duane Fronk, M.D.

According to 2025 Medicare claims, Bennjamin Fronk, M.D. (NPI: 1548587553) practices pain management in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is CENTRAL TEXAS PAIN CENTER, PLLC (NPI: 1891792776; TIN: 020721955) and primary practice location at 76712-6163. Fronk is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Fronk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 322 traditional Medicare patients, billed 3,564 HCPCS/CPT codes, and received $178,360 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 2,033 prescription claims across 352 beneficiaries totaling $80,015 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 83 records totaling $4,697. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $45,597 and ending at $178,360. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $30,338 and ending at $80,015. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	167	1,367	$45,597
2016	284	2,111	$107,213
2017	251	1,526	$90,154
2018	180	1,236	$86,828
2019	112	880	$56,875
2020	69	746	$29,978
2021	60	831	$43,799
2022	95	968	$64,382
2023	256	4,747	$207,481
2024	322	3,564	$178,360

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	218	681	$30,338
2016	368	2,094	$140,966
2017	301	1,883	$93,877
2018	230	1,482	$80,048
2019	149	812	$47,315
2020	87	500	$29,733
2021	82	467	$19,065
2022	170	606	$19,608
2023	317	2,321	$139,445
2024	352	2,033	$80,015

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	83	104	$206
62323	Injection of substance into lower spine canal using imaging guidance	66	78	$190
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	99	99	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	161	298	$90
J1100	Injection, dexamethasone sodium phosphate, 1 mg	135	1,536	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,190	32,368	$38,004
Belbuca	Buprenorphine Hcl	16	480	$11,718
Buprenorphine	Buprenorphine	24	651	$4,749
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	110	2,929	$3,165
Gabapentin	Gabapentin	99	4,235	$1,725

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$4,697	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bennjamin Duane Fronk, M.D.?

Tedicare shows public-source Medicare data for Bennjamin Duane Fronk, M.D. (NPI 1548587553), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bennjamin Duane Fronk, M.D. have ACO affiliation data?

Bennjamin Duane Fronk, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Bennjamin Duane Fronk, M.D.?

Bennjamin Duane Fronk, M.D. is linked to CENTRAL TEXAS PAIN CENTER, PLLC (billing NPI 1891792776) in the available physician profile data.

Does Bennjamin Duane Fronk, M.D. have Open Payments data?

Bennjamin Duane Fronk, M.D. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.